Recognizing ATTR-CM in High-Risk Populations
On the Frontlines of ATTR-CMRecognizing ATTR-CM in High-Risk Populations
Steve Jackson, PharmD
Frederick Ruberg, MD
Multidisciplinary Coordination in TK2d Diagnosis and Management
NeuroFrontiersMultidisciplinary Coordination in TK2d Diagnosis and Management
Charles Turck, PharmD, BCPS, BCCCP
Zarazuela Zolkipli-Cunningham, MBChB, MRCP
Oscar H. (Hank) Mayer, MD
Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies
Project Oncology®Evolving epNEC Care: From Default Regimens to Precision-Driven Strategies
Alexandria May, PharmD, BCPS
Chandrikha Chandrasekharan, MBBS
Redefining Cancer Care with Functional Precision Medicine
Project Oncology®Redefining Cancer Care with Functional Precision Medicine
Matt Birnholz, MD
Jim Foote, MBA
How KIT D816V Shapes Systemic Mastocytosis Diagnosis and Treatment
Clinician's RoundtableHow KIT D816V Shapes Systemic Mastocytosis Diagnosis and Treatment
Brian P. McDonough, MD, FAAFP
Thanai Pongdee, MD
Improving Diagnostic Accuracy in Systemic Mastocytosis
Clinician's RoundtableImproving Diagnostic Accuracy in Systemic Mastocytosis
Alexandria May, PharmD, BCPS
Tracy George, MD
- advertisement
Future-Proofing in HAE: Advances in Long-term Prophylaxis to Prevent Attacks and Improve Quality of Life
CME/CEFuture-Proofing in HAE: Advances in Long-term Prophylaxis to Prevent Attacks and Improve Quality of Life
Marc A. Riedl, MD, MS
Treatment of a Broader Population of Patients With DMD
CME/CETreatment of a Broader Population of Patients With DMD
Crystal Proud, MD
Erika Finanger, MD, MS
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
MinuteCE®Increasing ADH1 Awareness: A Hidden Cause of Hypoparathyroidism
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
CASR and ADH1: Integrating Biology and Genetic Screening
MinuteCE®CASR and ADH1: Integrating Biology and Genetic Screening
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
Therapeutic Options for ADH1 and Hypoparathyroidism
MinuteCE®Therapeutic Options for ADH1 and Hypoparathyroidism
Michael A. Levine, MD, FAAP, MACE, FACP
B. Michelle Schweiger, DO, MPH
- advertisement
- 05/25/2026
- 05/20/2026
- 05/14/2026
- 05/01/2026
- 05/01/2026
- 04/30/2026